ORAL ABSTRACTS
Meritorious Abstract 1: Treatment Sequencing and Survival Outcomes in Relapsed/Refractory Mantle Cell Lymphoma— Real-World Multi-Centre Singapore Experience *Awarded Best Oral Abstract
Joshua Loke1, Michelle Limei Poon2, Xiu Hue Lee1, Jing Yuan Tan1, Shin Yeu Ong1, Yunxin Chen1, Chandramouli Nagarajan1, Francesca Lim1, Aditi Manjeri Subramaniam1, Yeow Tee Goh1, Esther Chan2, Yogeshini Batumalai2, Jayalakshmi2, Ya Hwee Tan3, Esther Wei Yin Chang3, Nagavalli Somasundaram3, Jason Chan3, Jianbang Chiang3, Lawrence Cheng Kiat Ng1
1Singapore General Hospital, Haematology, Singapore, Singapore
2National Cancer Institute Singapore, Haematology, Singapore, Singapore, 3National Cancer Centre Singapore, Medical Oncology, Singapore, Singapore
Meritorious Abstract 2: REAL-WORLD ASIAN MULTI-CENTRE COHORT STUDY ON OUTCOMES OF POLA-R-CHP IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA
Nicole-Ann Lim1, Jing Yuan Tan2, Yi Chye Law1, Ya Hwee Tan1, 3, Jianbang Chiang1, 3, Esther Wei Yin Chang1, 3, Eileen Yi Ling Poon1, 3, Nagavalli Somasundaram1, 3, Cheng Kiat Lawrence Ng2, Keith Wong4, Michelle Limei Poon5, Soon Thye Lim1, 3, Jason Yongsheng Chan1, 3, Raymond Wong6.
1National Cancer Centre Singapore, Division of Medical Oncology, Singapore, Singapore,
2Singapore General Hospital, Department of Haematology, Singapore, Singapore,
3Duke-NUS Medical School, Oncology Academic Clinical Program, Singapore, Singapore,
4Pok Oi/Tin Shui Wai Hospital, Department of Medicine and Geriatrics, Singapore, Singapore,
5National University Health System, Department of Haematology-Oncology, Singapore, Singapore,
6Prince of Wales Hospital, The Chinese University of Hong Kong, Sir Y.K. Pao Centre for Cancer and Department of Medicine & Therapeutics, Hong Kong, China
Meritorious Abstract 3: Treatment Attrition Across Mantle Cell Lymphoma Care at a National Tertiary Cancer Center in Indonesia
Shafira Puspadina, Dwi Wahyunianto Hadisantoso, Noorwati Sutandyo
Dharmais Cancer Center
Meritorious Abstract 4: OUTCOMES OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH POLATUZUMAB VEDOTIN IN ST LUKE'S MEDICAL CENTER: AN ANALYTICAL STUDY
Jan Miko Aaron Baybay, Priscilla Caguioa
St Luke's Medical Center
Meritorious Abstract 5: Real-World Outcomes of Bispecific Antibody Therapy in Lymphoma: The Singapore Bispecific Registry and Experience (SABRE)
Jiao Jie Cherie Tan1, Jing Yuan Tan3,4, Christian Gallardo5 Nicole-Ann Lim6, Sanjay de Mel1, Esther H.L.Chan1, Yen Lin Chee1, Anand D. Jeyasekharan1,2, Shin Yeu Ong3,4, Chandramouli Nagarajan3,4, Francesca Wei Inng Lim3,4 Yunxin Chen3,4, Nagavalli Somasundaram4, Dheepa Christopher5 , Soon Thye Lim4, Jason Yongsheng Chan4, Michelle Limei Poon1 , Lawrence Cheng Kiat Ng3,4
1Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore
2Cancer Science Institute of Singapore, National University of Singapore, Singapore
3Department of Hematology, Singapore General Hospital, Singapore, Singapore.
4Division of Medical Oncology, National Cancer Centre Singapore
5Department of Haematology, Tan Tock Seng Hospital, Singapore
6Department of Medical Oncology, Singapore General Hospital, Singapore, Singapore
Meritorious Abstract 6: Repurposing Gefitinib as an Intervention for EGF-JAK/STAT Pathway Hyperactivation in Angioimmunoblastic T-cell Lymphoma
Ho Jun Jie Nicholas1, Huang Dachuan1, Lim Jing Quan1, Leonardo P. A. Biral2, Ng Wei Yi1, Nur Ayuni Binte Muhammad Taib1, Phang Beng Hooi1, Chai Xin Ye Kelila1, Jason Yong Sheng Chan1, Ong Choon Kiat1
1NATIONAL CANCER CENTRE SINGAPORE, Singapore
2Duke University, Durhan, United States
POSTER ABSTRACTS
Poster 1. Hematology Inflammatory Biomarkers of Anthracycline’s Cardiotoxicity in Lymphoma Patients
Amaylia Oehadian, Khrisna Yana, Astri Astuti
Department of Cardiology, Hasan Sadikin Hospital, Padjadjaran University, Bandung, Indonesia
Poster 2. Clinical and Inflammatory Biomarker Characteristics of Non-Hodgkin Lymphoma Patients in Dr. Moewardi General Hospital *Awarded Best Poster
Kun Salimah1, Agus Jati Sunggoro1, Aulia Safety Imron2, Ghazy Wira Pradipta2
1Division of Hematology and Medical Oncology Department of Internal Medicine, Dr. Moewardi General Hospital, Surakarta, Indonesia
2Faculty of Medicine, Sebelas Maret University, Surakarta, Indonesia
Poster 3. Body Mass Index and Chemotherapy Response in Diffuse Large B cell Lymphoma
Ade Erna, Harsya Nugraha, Lusi Mersiana, Amaylia Oehadian
Hematology and Medical Oncology Division, Hasan Sadikin Hospital, Padjadjaran University, Bandung, Indonesia
Poster 4. Current management of Primary Bone Marrow Lymphoma : A Systematic Review
Andree Kurniawan1, Chandra Sari2, Devi Astri Rivera Amelia3, Deden Djatnika4, Dimas Priantono5, Nugraheny Prasasti Purlikasari6, Beta Agustia Wisman5, Farieda Aryanti5, Nia Novianti Siregar7
1Hematologist and medical oncologist, Faculty of Medicine, Pelita Harapan University, MRCCC on Lippo Village, Tangerang, Banten, Indonesia
2Hematologist and medical oncologist, Dr Kanujoso Djatiwibowo hospital, Balikapapn, Indonesia
3Hematologist and medical oncologist, Ciawi general hospital, West Java, Indonesia
4Hematologist and medical oncologist, Primaya Hospital, Bekasi, West Java, Indonesia
5Hematologist and medical oncologist, Faculty of Medicine, Universitas Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia
6Hematologist and medical oncologist, Pelni Hospital, Jakarta Indonesia
7Hematologist and medical oncologist, Dharmais cancer center hospital, Jakarta, Indonesia
Poster 5. Real-World Efficacy of Frontline Pola-R-CHP versus R-CHOP/R-miniCHOP in Diffuse Large B-Cell Lymphoma: Outcomes in Immunohistochemistry-Defined High-Risk Subgroups from a Taiwanese Single-Center Cohort
Ling-Jung Chiu1, Hung-Lin Liu1, Ming-Chun MA1, Ming-Chung Wang1
1Kaohsiung Chang Gung Memorial Hospital, Division of Hematology and Oncology, Niaosong District,Taiwan
Poster 6. Real-World Evidence for Advanced Marginal Zone Lymphoma Treatment in Asia: Scoping Review
Gin Gin Gan1, Gerard Toh2, Jocelyn Leong2, Junice Ng3, Puja Khanna3, Jason Yongsheng Chan4,5
1University of Malaya, Malaysia; 2Tech Observer Asia Pacific, Singapore; 3BeOne Medicines, Singapore; 4National Cancer Centre Singapore, Singapore; 5Duke-NUS Medical School, Singapore
Poster 7. Key Factors in Managing B-cell Non-Hodgkin’s Lymphoma in Limited- and Well-Resourced Hospitals in Southeast Asia
Michelle Poon1, Priscilla Caguioa2, Kitsada Wudhikarn3, Gin Gin Gan4, Huynh Van Man5, Damai Santosa6, Junice Ng7, Puja Khanna7, Neeyor Bose8, Amanda Woo8, Yi Qi Ng8, Lalita Norasetthada9
1Department of Hematology-Oncology, National Cancer Institute Singapore, Singapore; 2Department of Medicine, St. Luke’s Medical Center, Philippines; 3Division of Hematology, Department of Medicine, Chulalongkorn University, Thailand; 4Department of Medicine, Universiti Malaya, Malaysia; 5Department of HSCT, Blood Transfusion Hematology Hospital, Vietnam; 6Division of Hematology Medical Oncology, Department Oncology, Dr. Kariadi Hospital/Faculty of Medicine, Diponegoro University, Indonesia; 7BeOne Medicines Singapore Pte. Ltd., Singapore, Singapore; 8Oracle Life Sciences; 9Faculty of Internal Medicine, Chiang Mai University, Thailand
Poster 8. Serial Tumour-Informed Circulating Tumour DNA as a Complement to Radiological Response Assessment in Diffuse Large B-Cell Lymphoma
Noorwati Sutandyo1, Lyana Setiawan2, Grace Shalmont3, Christine Sugiarto2, Yuniar Harris Prayitno1
1Department of Haematology and Medical Oncology, Dharmais National Cancer Centre Hospital, Jakarta, Indonesia
2Department of Clinical Pathology, Dharmais National Cancer Centre Hospital, Jakarta, Indonesia
3Department of Anatomical Pathology, Dharmais National Cancer Centre Hospital, Jakarta, Indonesia
Poster 9. COST-EFFECTIVENESS OF OPTIM.AI®-GUIDED THERAPY IN RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA
Weng Tong Ho1, William Wee Lee Chan2, Yi Ching Yuen2, Rui Xue Lee2, Michelle Limei Poon2, Sanjay de Mel2, Anand D Jeyasekharan2, Andreas Voss1, Edward Chow1
1KYAN Technologies Pte Ltd, Singapore
2National University Hospital, Singapore
Poster 10. Optim.AI™ 2.0 for ex vivo functional profiling of immunotherapy combinations in relapsed/refractory non-Hodgkin’s lymphoma
Sharon Pei Yi Chan1, Jhin Jieh Lim1, Masturah Mohd Abdul Rashid1, Sanjay De Mel2, Anand D Jeyasekharan3, Edward Kai-Hua Chow1
1KYAN Technologies Pte Ltd, Singapore
2Department of Hematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore
3Cancer Science Institute of Singapore, National University of Singapore, Singapore
Poster 11. Unmasking Atypical Double-Hit Lymphoma: AI-Powered High-Throughput Karyotyping and Dual FISH Probe Strategy
Ying Wang, Qinlu Li, Shugang Xing, Xia Mao, Min Xiao, Jia Wei
Department of Hematopathology of Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Poster 12. Peripheral T-cell lymphoma NOS with dual TCR-β and TCR-δ expression presenting as an incidental anterior mediastinal mass
Alfonso Tan-Garcia1, Grace Fang Min Tan1, Lawrence Cheng Kiat Ng2,3 and Chee Leong Cheng1
1Department of Anatomical Pathology, Singapore General Hospital, Singapore
2Department of Haematology, Singapore General Hospital, Singapore
3Department of Haematology, National Cancer Centre Singapore, Singapore
Poster 13. PAX5-Rearranged t(9;14)(p13;q32) Diffuse Large B-Cell Lymphoma: A Single-Institution Experience of 5 Cases and Potential for Targeted Therapy
Qinlu Li, Shugang Xing, Min Xiao and Ying Wang
Department of hematology, Tongji hospital, Tongji medical College, huazhong university of Science and Technology, Wuhan, China
Poster 14. Diagnostic Pitfalls in Sezary Syndrome: Histopathological and immunophenotypic Clues in a case Initially Misdiagnosed as Chronic Dermatosis
Krisna Murti1, Erty Sundarita2, Nora Ramkita3
1Department of Anatomic Pathology Faculty of Medicine Universitas Sriwijaya/Dr. Mouhammad Hoesin Palembang Hospital
2Department of Internal Medicine Sekayu Regional General Hospital
3Department of Anatomic Pathology Dr. Rivai Abdullah Palembang Hospital
Poster 15. Chronic Eczema Masking Advanced Primary Cutaneous Anaplastic Large Cell Lymphoma: A Case Report
Chong Guang Yong1, Lailatulema Abbas1 , Siti Nor Hakimah Hashim2 , Vinodhinii Sankaran1, Sivakumar Palaniappan3, Nor Rafeah Tumian2
1Clinical Haematology Unit, Department of Medicine, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia
2Clinical Haematology Unit, Department of Medicine, Faculty of Medicine, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia
3Hospital Pantai Kuala Lumpur, Jalan Bukit Pantai, Bangsar, 59100 Kuala Lumpur, Wilayah Persekutuan
Poster 16. SMARCB1-deficient peripheral T-cell lymphoma in a 17-year-old male - an emerging entity which expands spectrum of SMARCB1-deficient tumours
Laura Ling Ying Tan1, Daryl Tan Chen Lung2, Andy Tang Sing Ong3, Chang Kian Meng, Hon Siong Leng3, Ho Kim Wah3, Cheng Chee Leong1
1Department of Anatomical Pathology, Division of Pathology, Singapore General Hospital
2Clinic for Lymphoma, Myeloma and Blood Disorders, Mount Elizabeth Hospital Novena Specialist Centre, Singapore, Singapore
3Sunway Medical Centre, Department of Haematology, Kuala Lumpur, Malaysia
Poster 17. Turning the Tide in Relapsed DLBCL With Secondary CNS Involvement: R-ICE Plus Glofitamab as a Bridge to Autologous Transplant
Yang Liang Boo, Christopher Chin Keong Liam, Soo Min Lim
Haematology Unit, Department of Medicine, Sultanah Aminah Hospital, Johor Bahru, Johor, Malaysia
Poster 18. Lymphoblastic Lymphoma, Rare and Aggressive Lymphoid Malignancy: A Case Series of Patients in Dharmais Cancer Hospital Indonesia
Nia Novianti Siregar, Sri Agustini Kurniawati, Dwi Wahyunianto H, Shafira Puspadina
Hematology and Medical Oncology Department, Dharmais Cancer Hospital, Indonesia
Poster 19. We Could Have Missed!
Than Zaw1, Vivek Radhakrishnan1, Andrew Davies1,2
1Department of Haematology/Division B (Cancer Care), University Hospital Southampton NHS Foundation Trust, Southampton, UK
2Department of Cancer Sciences, University of Southampton, Southampton, UK
Poster 20. Case report of a composite lymphoma: peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) with low-grade follicular lymphoma (FL)
Gabriella Soh Si Hui1, Laura Tan Ling Ying1, Kevin Tay Kuang Wei2, Cheng Chee Leong1
1Department of Anatomical Pathology, Singapore General Hospital
2OncoCare Cancer Centre, Singapore
Poster 21. Multidisciplinary management of double-expressor DLBCL in pregnancy
Carmen Lee
Queen Mary Hospital